Programme

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​BEST COMMUNICATIONS AWARDS

30 June 2015

Best Communications Awards - 30 June 2015.pdf

29 June 2015Best Communications Awards - 29 June 2015.pdf
28 June 2015Best Communications Awards - 28 June 2015.pdf

Saturday, 27 June

14:00 to 15:00​
Auditorium​​

Welcome session
Speakers: Gonzalo Calvo (Spain), Tabasso​​me Simon (France), ​Ylva Böttiger (Sweden) 

  • Introduction of EACPT a​nd welcome to first-time attendees
  • Evolutio​n of the EACPT over the last y​ears
  • Challenges and opportunities for EACPT and Clinical Pharmacology​
    • Clinical Pharmacology as a medical speciality in the EU
    • EACPT as the common h​ouse of clinical pharmacology as a discipline
    • Professional development in Clinical Pharmacology
15:00 to 16:00
Poster Area
Coffee break and Guided poster session (1)
16:00 to 17:30
Auditorium

Medicines and Global Health 
Time to revisit the role of stakeholders in global health

Chairs: Lembit Rägo (WHO) and Adrián LLerena (Spain)

  • Re-engineering the WHO Essential Medicines process: Moving towards a Globally applicable model.                     ​ ​   ​    ​  ​  ​   Nicola Magrini (WHO, S​witzerland)
  • Global Pharmacovigilance In the global context. Prequalification Programme.                                             ​  ​Lembit Rägo (WHO, Switzerland)
  • The role of private initiatives in facilitating access to the medicines in the disadvantages settings.                                ​   ​Raj Long (Bill and Melinda Gates Foundation, United Kingdom)
  • The accelerated access to investigational medicines.  Scientific and ethical issues around the Ebola outbreak.         ​    ​ ​      ​Antoni Plasencia (Sp​ain)
17:30 to 18:00
Auditorium​

Opening ceremony

Welcome talks from Ministry of Health, chairs of the congress, chair of SEFC.​​​​

18:00 to 19:00
Auditorium

Lifetime achievement award

Chair​: Gonzalo Calvo (Spain)

  • Plenary lecture: Pharmacogenomics and individualized drug therapy: Where do we stand in 2015.

       Michael Eichelbaum (Germany) ​​​

19:00
Exhibition Area
Welcome cocktail

 

 

 

 

 

Sunday, 28 June 


8:00 to
 9:00
Auditorium

8:00 to
 9:00
Room Castilla

8:00 to 9:00
Room Hidalgo

Oral Comunications
Oral communications 1​
Chair: Magi Farré (Spain)

Oral communications 2

Chair: Pedro Zapater (Spain)​

Oral communications 3
Chair: Clara Rosso (Sp​ain)

  9:00 to 10:30

 Auditorium

TRACK 1 (Medicines regulation)

Biosimilar medicinal products. How to enhance healthcare systems sustainability without compromising clinical practice.

Chairs: Arantxa Sancho (Spain) and Dinko Vitezic (Croatia)

  • Biosimilar regulation in the EU. Trends for the future (e.g. extrapolation of indications, how to conciliate therapeutic equivalence demonstration with assay sensitivity).
    Martina Weise. (Germany)
  • Challenging issues of the introduction of biosimilar in clinical practice: interchangeability, substitution, and traceability. 
    Cristina Avendaño-Solá. (Spain)
  • Impact of biosimilar medicinal products in the EU pharmaceutical market.
    Aleksandra Grozdanova (Macedonia)

Discussant: Sol Ruiz, (Spain)​​

  9:00 to 10:30

 Room Castilla

TRACK 2 (Research)

Novel insight in ADME.​

Chairs: Mª Angeles de Cos (Spain) and Ingolf Cascorbi (Germany)

  • Impact of bariatric​ surgery on drug-transport and metabolism.

      Werner Siegmund (Germany)​

  • Drug interactions at the level of influx transporters. 

    Janne Backman, (Finland)​​

  • ​Physiologically-based pharmacokinetic models to predict ADME in humans.
      Amin Rostami (United Kingdom​)

 

 9:00 to 10:30

 Room Hidalgo

TRACK 3 (Clinical practice)

Handling medicines in special populations.
Chairs: Erna Beers (Netherlands​) and José Antonio Serra (Spain)

  • Renal function in older people - validity of MDRD/CG/CKD-EPI and implication for clinical practice.

      Emmanuelle Vidal-Petiot (France)

  • Rational pharmacotherapy in children - issues concerning off-label drug use. ​
      Imti Choonara (United Kingdom)

 
  • Update in strategies for appropriate prescription in older patients.
      Beatriz Montero (Spain)​

 
10:30 to 11:00
Exhibition
Coffee break

11:00 to 12:30

Auditorium

TRACK 1 (Medicines regulation)

Drug development for regulatory approval and reimbursement decisions. Is a seamless strategy feasible?  
Chair: Bruno Flamion (Belgium) and Xavier Llaurado (Spain)​

  • What is lacking in the regulatory package to support reimbursement decisions?
    Beate Wieseler (Germany)
  • The view of the regulator.
    Pierre Demolis (France)​
  • Shifting the marketing authorisation paradigm? Adaptive licensing:  a valid approach nowadays?
    Bruno Flamion (Belgium)

11:00 to 12:30

Room Castilla

TRACK 2 (Research)

Prioritisation of research: Criteria and key factors for a successful research In Europe.
ChairsGonzalo Arévalo (Spain) and Tabassome Simon (France)

 

  • ​Public support to independent clinical trials.​                         Rafael de Andrés Medina​ (Spain)​​
  • Clinical Research networks. ​​
    Jacques Demotes (France)​
  • Public-private partnership in clinical research.​    ​                   Javier Urzay (Spain)

11:00 to 12:30

Room Hidalgo

TRACK 3 (Clinical practice)

Implementation of Pharmacogenetics and Personalised Medicine in Clinical Practice from a Health Care perspective: What is a clinical need and what is just busine​​ss?​

Chairs: ​Guilherme Suarez-Kurtz (Brazil)

  • Health care model approaches                                           Mathias Schwab (Germany)​​
  • Pharmacoeconomic evaluation of pharmacogenomics in healthcare systems. 
  • Raul A. Kiivet (Estonia)

    Discussants: Kim Brosen (Denmark), Ingolf Cascorbi (Germany), Edoardo Spina (Italy), Adrián LLerena (Spain), Marja-Liisa Dahl (Sweden)

12:30 to 14:00
Poster Area
Lunch – Guided Poster Session (2)
​14:00 to 15:30
Room Auditorium

PARALLEL SESSIONS

TRACK 3 (Clinical practice)​

Interventions that improve the use of medicines in clinical practice.

Chairs:Antonio Portolés (Spain) and ​Milan Gr​undman (Czech Republic) ​

  www.farmakologiportalen.no. A common national database           for pharmacological laboratory services. 
        Tormod K Bjånes (Norway)

 
   Promoting utility of PK/TDM principles among practitioners          facilitates dialog towards rationalization of drug use. 
         Romaldas Maciulaitis (Lithuania)

 
   Personalised pharmacotherapy in routine clinical                           pharmacological practice
          Milan Grundmann (Czech Republic)

 
    UK Translational Medicine and Therapeutics (TMAT) PhD               Training. 
          David J. Webb (United Kingdom)

 
   Increasing the number of adverse drug events by the use of          an adverse drug event manager (ADEM). 
         Espen Jimenez-Solem (Denmark)​​


 

14:00 to 15:30
Room Castilla

TRACK 2 (Research)​

Clinical research in Alzheimer.

Chairs: Edoardo Spina (Italy) and Fernando de Andrés (Spain) 

  • State-of-the art pharmacological interventions in Alzheimer therapy

      Pablo Martínez Lage (Spain) ​

  • Biomarkers in Alzheimer clinical research​ 

      Claudio Babiloni (Italy)

  • How challenge test can improve the sensitivity of the biomarker battery to test symptomatic treatments.

       Davi​d Bartrés-Faz (Spain)​​

  • Disease-modifiers in Alzheimer's disease : towards multimodal strategies                                                               ​     ​   ​     ​​Régis Bordet (France)​​


 

14:00 to 15:30
Room Hidalgo

TRACK 3 (Clinical practice)​

Interventions that improve the use of medicines in clinical practice.

Chairs: Antonia Agustí (Spain) and Gerard Rongen (EACPT)

• A compu​terized physician order entry-based system to prevent HBV reactivation in patients treated with biologic agents. The PRESCRIB Project. 

Cándido Hernández-López (Spain)

 
• Systematic introduction of new therapies within the Stockholm county and the Karolinska University Hospital. 

Carl-Olav Stiller (Sweden)

 
• Initiative o​n medication reviews and dialogues. 
Mikkel Christensen (Denmark)


 
• E learning on pharmacotherapy for starting physician in the hospital. What they need to know. 
Cornelis Kramers (The ​Netherlands)

 
• Courses in clinical pharmacology for nurses and young doctors – narrowing the gap of ignorance? 
Kirstine Moll Harboe (Denmark)​
 
15:30 to 16:00
Exhibition Area
Coffee break
16:00 to 17:00
Auditorium

PLENARY DEBATE

Pharmacoepidemiology databases are good and accessible? Yes, No, Perhaps?

Chair: Susana Pérez-Gutthann (Spain) and Dolores Montero (Spain)

Speakers:

  • Miriam Sturkenboom (The Netherlands)
  • Tom MacDonald (United Kingdom)
17:00 to 17:30
Auditorium
Best communication award 
17:30 to 19:00
Auditorium



 


 


 


 


 


 


 


 


 


 

17:30 to 19:00   Room Castilla


 


 


 


 


 


 


 

17:30 to 19:00​   Room Hidalgo

SYMPOSIUM OF THE CD IUPHAR- EACPT 2015: Clinical Networks and Consortia in Drug-Induced Liver Injury (DILI): An opportunity for advancing Safety Sciences.

Chair: Maribel Lucena (Spain) 

  • Clinical DILI Networks and Consortia: What lessons have we learnt?                                                                                   Raúl Andrade (Spain)    
  • The DILI-sim Initiative. Integrated systems pharmacology–based to explain and predict drug hepatotoxicity.
    Paul​ Watkins (USA)
  • Joint efforts for the Development and qualification of Biomarkers in DILI. Where do we stand now?
    Michael Merz (Switzerland)    
  • How to detect, evaluate and minimize the risks: An European point of view.                                                                         ​Herve Le Louet (France)

TRAINING COURSE ON MEDICINES REGULATION: How the EU Regulatory network deals with divergent views.

Chair: Arantxa Sancho (Spain)

  • General considerations about CHMP opinions                       Martina Weise​, Arantxa Sancho
  • Presentation of two controversial examples
    Jorge Camarero, Ferran Torres, Antonio Gomez-Outes
  • Open discussion                                                                   Martina Weise, Arantxa Sancho, Jorge Camarero, Ferran Torres, Antonio Gomez-Outes + all attendees

AUTHOR'S WORKSHOP​


19:00 to 20​:00
Room Hidalgo
EACPT Council​​
Only EACPT Members​

 

Monday, 29 June


8:00 to
 9:00
Auditorium

8:00 to
 9:00
Room Castilla



8:00 to 9:00
Room Hidalgo
Oral Comunications

Oral communications 4                                                       Chair: Belén Ruiz Antorán (Spain) and Monica​ Saldaña (Spain)

Oral communications on CPT education 5                                      Chair: Luc van Bortel (Belgium) and Dolores​ Capellà (Spain)


 

Oral communications 6​                                                              Chair: Francisco Abad (Spain) and Antonio Gomez-Outes (Spain)​

  9:00 to 10:30

 Auditorium

TRACK 1 (Medicines regulation)

Medicines regulation and access to medicines.

Chair: Alar Irs (Estonia) and Josep Torrent (Spain)

  • Role of physicians in drug selection policies. A neglected responsibility?​
    Denis Pouchain (France)
  • Listen to the patients' voice in pricing/reimbursement policies and drug selection decisions.
    Nick Meade (United Kingdom) ​​​
  • Spending for medicinal products in the face of strong innovation and hard economic crisis
    Toni Gilabert (Spain)
    (Catalan experience with risk sharing schemes)

  9:00 to 10:30

 Room Castilla

TRACK 5 (Education)

Novel approaches in CPT education

Chairs: José Nicolás Boada (Spain) and Theo de Vries (The Netherlands)

  • Student-led education​.
    Michel v. Agtmael (The Netherlands)​​
  • Junior doctor-led 'near-peer' education. 
    Simon Maxwell (United Kingdom)
  • Internet-based solutions to alleviate shortages of pharmacology faculty in developing countries                           ​ ​    ​     ​    ​Leszek Wojnowski (Germany)​​
  • EACPT Education Award (ceremony + prizewinner lecture)

 9:00 to 10:30

 Room Hidalgo

TRACK ​3 (Clinical practice)

Heterogeneity in drug response: Pharmacological determinants and their regulatory and clinical implications. 
Chair: José Antonio Sacristán (Spain) and Marie Besson (Switzerland)

  • ​Understanding the pharmacological factors that influence heterogeneity in drug response.                                           Juan Tamargo (Spain)
  • Heterogeneity, the problem with the averages and the new regulatory challenge: "whom to treat".

      Caridad Pontes (Spain)

  • Variability in drug response and clinical reality: the example of psychiatric diseases.

      Eduard Vieta (Spain)​​

10:30 to 11:00
Echibition Area
Coffee break
11:00 to 12:30
Auditorium

PARALLEL SESSIONS

 
The Immunopharmacology of TNF-alpha: Disease transcending therapies. EACPT, EPHAR & IUPHAR Joint session.

 

Chairs: Aletta Kraneveld (The Netherlands) and Antoni Vallano (Spain)

  • Targeting TNF receptors in neurodegenerative diseases.              Roman Fischer (Germany)
  • Optimizing anti-TNF therapy in patients with IBD.                  ​Johannan Brandse (The Netherlands)
  • Vaccination against cytokines in rheumatoid arthritis: a new frontier for anti-TNF alpha therapies?                                     ​Marie Christophe Boissier (France)
​​
11:00 to 12:30
Room Castilla

TRACK 5 (Education)

​​Major initiatives in CPT education.

Chairs: Simon Maxwell (United Kingdom) and Jelle Tichelaar (The Netherlands)​ 

 

  • eLearning: the PharmaTrain experience                                Jean-Marie Boeynaems (Belgium) 

 

 

  • ​The Dutch/Flemish prescribing assessment project.         ​Cornelis Kramers (The Netherlands)

  • Update on European Research on CPT education projects -  EACPT-STUDY: Final-year students' core knowledge and competence of pharmacotherapy: a multicenter European explorative study (Working group Research on CPT Education of the Education subcommittee of the EACPT)
     
  • Update on European and international CPT education projects - Education subcommittee of the EACPT
    -IUPHAR Education Project
    -EACPT teaching network​
    -WHO Guide to Good Prescribing
    -Prescribing Safety Assessment
    -TRC Leiden
11:00 to 12:30
Room Hidalgo

TRACK 6 (Pharmacovigilance)

Risks communication to health professionals and citizens.

 Chairs: Dolores Montero (Spain) and Cristina Cabrita (Portugal)

  • ​Challenges in communicating risks:​

      Barbara Rath (German​​y)

  • On-going initiatives for improv​ing communication.

      Almath Spooner (Ireland)

  • How risks are perceived. Case studies. 

      Frederic Bouder (The Netherlands)

12:30 to 14:00
Poster Area

Lunch – Guided Poster Session (3)

EACPT Committee Meeting​

14:00 to 15:30
Auditorium
PARALLEL SESSIONS

TRACK 3 (Clinical practice)

 
Drug Information and Decision Support Systems to support rational drug treatment.
Chairs: Ylva Böttiger (Sweden) and  Ana Aldea (Spain)

 
  • Standards in drug information and communication.

             Robert Van der Stichele (Belgium)​

  • The Sfinx/Pharao CDSS on drug-drug interactions and pharmacodynamics.

             Ylva Böttiger (Sweden)

  • Alert fatigue – an overdose of drug i​nfor​mation?

            Heleen van der Sijs (The Netherlands)

  • The Drug Information Center in 2015 – still a valid concept?

             Linda Amundstuen Reppe (Norway)


14:00 to 15:30
Room Castilla

TRACK 2 (Research)

State-of-the-art in treatment of type II diabetes.

Chairs: Kim Brosen (France) and Joan-Albert Arnaiz (Spain)

  • ​Incretines – safety and efficacy.

      Michael A. Nauck (Germany)

  • SGLT2 inhibitors.

       Miguel Brito (Spain)

  • Gene-Environment Interactions in Type 2 Diabetes.

       Paul W. Franks (Sweden)

14:00 to 15:30
Room Hidalgo

TRACK 6 (Pharmacovigilance)

New immunosuppressant therapies: Challenges in Pharmacovigilance

Chairs: Miguel Angel Maciá (Spain) and Caroline Samer (Switzerland)

  • Hepatitis B​ reactivation. How to manage the risk?                ​José Luis Calleja (Spain)
  • Progressive multifocal leukoencephalopathy. Risk perception in the therapeutic context.                                                 Brigitte Keller-Stanislawski (Germany)
  • Registries for long-term risks.                                         ​      ​Ignacio García Doval (Spain)​​
15:30 to 16:00
Exhibition Area
Coffee break
16:00 to 17:00
Auditorium

PLENARY DEBATE
Therapeutic innovation:  Does industry research meet the needs of society?
Chair: Francisco de Abajo (Spain) and Gonzalo Calvo (Spain)

Speakers:

  • Xavier Carné (Spain): defending No.
  • Ruth Diazaraque (United Kingdom): defending Yes.​ 
17:00 to 17:30
Auditorium
Best communication award (2)
17:30 to 19:00
Auditorium






17:30 to 19:00
Room Castilla

Satellite Symposium                                                                            Industry Session not included in main event CME/CPD credit​​​​

See details at: http://www.eacpt2015.org/support-exhibition/satellite-symposia#.VVmz3fntmko​​

​​

Satellite Symposium                                                                            ​Industry Session not included in main event CME/CPD credit​​​​

See details at: http://www.eacpt2015.org/support-exhibition/satellite-symposia#.VVmz3fntmko​​

​19:00 to 20​:00
Room Hidalgo
SEFC ASSEMBLY​​

 

Tuesday, 30 June

 
8:00 to   9:00
Auditorium



8:00 to
   9:00
Room Castilla


8:00 to   9:00
Room Hidalgo
Oral Comunications 

Oral communications 7

Chair: Mª Angeles Galvez (Spain)​


Oral communications 8

Chair: Rubin Lubomirov (Spain)​


 

Oral communications 9

Chair: Ana Isabel​ Terleira (Spain)

9:0​0 to 10:00

Auditorium

 

Plenary Lecture

Chair: Tabassome Simon (EACPT elected chair)

  • ​Current challenges in cancer treatment.
​      Luis Paz Ares (Spain)

 

10:00 to 11:00
Auditorium
EACPT Scientific Award​ and Joint EACPT-EPHA​R Awards
11:00 to 11:30
Exhibition Area

Coffee break

11:30 to 12:30
Auditorium

Establishing an EACPT network.

Gonzalo Calvo (Spain) / Ylva Bö​ttiger (Sweden)

12:30 to 12:45
Auditorium

Closing ceremony

Chair: Tabassome Simon (France)​

  • Best communication award (3)​​
  • Talks from chair of the meeting, chair of the SEFC and new chair of EACPT
13:00 to 14:30
Auditorium

EACPT Networking Event

Donald Singer (United Kingdom)/ Caridad Ponte​s (Spain)

Keep Me Updated